4164 CHENG UEI: Dividend Resolution for Key Subsidiary Xingye Biotech
CHENG UEI announced that its key subsidiary, Xingye Biotech, has resolved to distribute cash dividends.
📋 Article Processing Timeline
- 📰 Published: May 26, 2026 at 06:31
- 🔍 Collected: May 26, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 20:16 (133h 45m after Collected)
On May 25, 2026, CHENG UEI (4164) announced that its key subsidiary, Xingye Biotech Co., Ltd., held a board meeting and resolved to distribute cash dividends. The total amount of the cash dividend is 41,827,852 TWD. There are no other matters to be noted.
FAQ
What is CHENG UEI's main business?
Medical equipment sales and maintenance.